Builds a digital model to assess myasthenia gravis using body data
Collects digital signals, videos and movement data from adults with myasthenia gravis.
Plain-language title generated from the registry record
Registry title: Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Key facts
- Where
- Shanghai, ChinaSee the site
Where in China
- Huashan Hospital Affiliated to Fudan UniversityShanghai, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Huashan Hospital
- Trial code
- NCT07146425
- Record updated
- 28 August 2025
- Original description
This research is a single-center, exploratory, observational study to be carried out in the outpatient or inpatient ward of the Neurology Department at Huashan Hospital, affiliated to Fudan University. The aim is to develop a digital assessment model for Myasthenia Gravis by gathering multimodal digital phenotypic data from MG patients. This includes physiological signals, facial videos, eye movements, speech, limb movements, various scales, and quality of life metrics.Read full original descriptionShow less
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
This research is a single-center, exploratory, observational study to be carried out in the outpatient or inpatient ward of the Neurology Department at Huashan Hospital, affiliated to Fudan University. The aim is to develop a digital assessment model for Myasthenia Gravis by gathering multimodal digital phenotypic data from MG patients. This includes physiological signals, facial videos, eye movements, speech, limb movements, various scales, and quality of life metrics.
Inclusion: For Patients with MG; Patients have a confirmed diagnosis of myasthenia gravis and be over 18 years old; Patients have the clinical classification of Myasthenia Gravis Foundation of America (MGFA) within I-IV, or be asymptomatic after treatment; Patients must sign the informed consent form and the privacy confidentiality agreement; For Healthy Participants; Age group matched with MG participants.
Exclusion: Patients are with severe cardiopulmonary diseases and unable to cooperate with the scoring; Patients with any psychiatric disorder or cognitive dysfunction that, in the investigator's judgment, may interfere with their participation in the study; Patients with any other unspecified unstable medical condition; For Patients with MG; Patients are in the crisis stage of myasthenia gravis (MGFA class V) and unable to cooperate with scoring.